Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Excellent medical, dental, and vision coverage.
Qu’est-ce qui vous rend le plus heureux au travail?
Celebrating success achieved as a team.
Quelles sont les meilleures choses à propos de votre équipe?
We all work hard together to meet deadlines and help patients.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The leadership team is connected to everyone, not isolated in a board room.
Other Employee Reviews for Karyopharm Therapeutics
×